BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) shares shot up 13.6% during mid-day trading on Tuesday . The stock traded as high as $4.45 and last traded at $4.35. 286,995 shares were traded during trading, an increase of 15,338% from the average session volume of 1,859 shares. The stock had previously closed at $3.83.
BriaCell Therapeutics Trading Up 13.6 %
The firm has a market capitalization of $3.36 million, a PE ratio of -0.01 and a beta of 1.09. The stock has a 50 day simple moving average of $1.66 and a 200 day simple moving average of $1.08.
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.
Recommended Stories
- Five stocks we like better than BriaCell Therapeutics
- Stock Analyst Ratings and Canadian Analyst Ratings
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Buy P&G Now, Before It Sets A New All-Time High
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- 10 Best Airline Stocks to Buy
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
